DGAP-News: Epigenomics AG Reports Financial Results for the First Nine Months 2019

Berlin (Germany) and San Diego, CA (USA), November 19, 2019 - Epigenomics AG (FSE: ECX, OTCQX: EPGNY, the "Company") today announced its financial results (IFRS, unaudited) for the first nine months of 2019.